P874: DECIPHERING PLASMA CELL HETEROGENEITY AND TUMOR MICROENVIRONMENT IN LIGHT‐CHAIN AMYLOIDOSIS USING SINGLE CELL RNA‐SEQUENCING von Srivastava, A., Kumari, R., Adhikari, S., Sergeev, P., Miettinen, J. J., Suvela, M. H., Flanagan, K., Slipicevic, A., Nupponen, N. N., Lehmann, F., Heckman, C.

Volltext

A peptidase-potentiated alkylating agent melflufen is effective anti-neoplastic agent in osteosarcoma von Byrgazov, K., Slipicevic, A., Lehmann, F., Lion, T., Kager, L., Taschner-Mandl, S.

Volltext

1726PA peptidase-potentiated alkylating agent melflufen is effective anti-neoplastic agent in osteosarcoma von Byrgazov, K, Slipicevic, A, Lehmann, F, Lion, T, Kager, L, Taschner-Mandl, S

Volltext

1726P - A peptidase-potentiated alkylating agent melflufen is effective anti-neoplastic agent in osteosarcoma von Byrgazov, K., Slipicevic, A., Lehmann, F., Lion, T., Kager, L., Taschner-Mandl, S.

Volltext

264 Sensitization of melanoma cells to TRAIL-R2 agonist antibody by low-dose anisomycin von Slipicevic, A, Øy, G.F, Engesæter, B, Mælandsmo, G.M, Flørenes, V.A

Volltext

Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome von Slipicevic, Ana, Holm, Ruth, Nguyen, Mai T P, Bøhler, Per J, Davidson, Ben, Flørenes, Vivi Ann

Volltext

Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2 von Jørgensen, Kjersti, Skrede, Martina, Cruciani, Véronique, Mikalsen, Svein-Ole, Slipicevic, Ana, Flørenes, Vivi Ann

Volltext

Anchorage-independent survival of human melanoma cells: cooperation between activation of the MAPK/ERK1/2 pathway and lack of PTEN induction von Slipicevic, A., Skrede, M., J??rgensen, K., Fl??renes, V.

Volltext

The one‐carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation von Marttila, P, Bonagas, N, Chalkiadaki, C, Stigsdotter, H, Schelzig, K, Shen, J, Farhat, C.M, Hondema, A, Albers, J, Wiita, E, Rasti, A, Warpman Berglund, U, Slipicevic, A, Mortusewicz, O, Helleday, T

Volltext bestellen

Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells von Green, A.C, Marttila, P, Kiweler, N, Chalkiadaki, C, Wiita, E, Cookson, V, Lesur, A, Eiden, K, Bernardin, F, Vallin, K.S.A, Borhade, S, Long, M, Ghahe, E.K, Jiménez-Alonso, J.J, Jemth, A.-S, Loseva, O, Mortusewicz, O, Meyers, M, Viry, E, Johansson, A.I, Hodek, O, Homan, E, Bonagas, N, Ramos, L, Sandberg, L, Frödin, M, Moussay, E, Slipicevic, A, Letellier, E, Paggetti, J, Sørensen, C.S, Helleday, T, Henriksson, M, Meiser, J

Volltext bestellen

MX 2 is a novel regulator of cell cycle in melanoma cells von Juraleviciute, M, Pozniak, J, Nsengimana, J, Harland, M, Randerson‐Moor, J, Wernhoff, P, Bassarova, A, Øy, GF, Trøen, G, Flørenes, VA, Bishop, DT, Herlyn, M, Newton-Bishop, J, Slipicevic, A

Volltext bestellen

KIT in Melanoma: Many Shades of Gray von Slipicevic, Ana, Herlyn, Meenhard

Volltext

High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy von Magnussen, Gry Irene, Holm, Ruth, Emilsen, Elisabeth, Rosnes, Anne Katrine Ree, Slipicevic, Ana, Flørenes, Vivi Ann

Volltext

The one‐carbon metabolic enzyme MTHFD2 promotes resection and homologous recombination after ionizing radiation von Marttila, Petra, Bonagas, Nadilly, Chalkiadaki, Christina, Stigsdotter, Hannah, Schelzig, Korbinian, Shen, Jianyu, Farhat, Crystal M., Hondema, Amber, Albers, Julian, Wiita, Elisée, Rasti, Azita, Warpman Berglund, Ulrika, Slipicevic, Ana, Mortusewicz, Oliver, Helleday, Thomas

Volltext

Effect of ABCB1 Multidrug Resistance Protein on Efficacy of Anti-Myeloma Drugs in Carfilzomib-Resistant Myeloma Model von Byrgazov, Konstantin, Kraus, Marianne, Besse, Andrej, Slipicevic, Ana, Lehmann, Fredrik, Driessen, Christoph, Besse, Lenka

Volltext

Expression and clinical role of DJ-1, a negative regulator of PTEN, in ovarian carcinoma von Davidson, Ben, MD, PhD, Hadar, Rivka, MSc, Schlossberg, Anat, BSc, Sternlicht, Tamar, MSc, Slipicevic, Ana, MSc, Skrede, Martina, Risberg, Björn, MD, PhD, Flørenes, Vivi Ann, PhD, Kopolovic, Juri, MD, Reich, Reuven, PhD

Volltext

MX 2 is a novel regulator of cell cycle in melanoma cells von Juraleviciute, Marina, Pozniak, Joanna, Nsengimana, Jérémie, Harland, Mark, Randerson‐Moor, Juliette, Wernhoff, Patrik, Bassarova, Assia, Øy, Geir Frode, Trøen, Gunhild, Flørenes, Vivi Ann, Bishop, David Timothy, Herlyn, Meenhard, Newton‐Bishop, Julia, Slipicevic, Ana

Volltext

Up-regulation of multidrug resistance protein MDR1/ABCB1 in carfilzomib-resistant multiple myeloma differentially affects efficacy of anti-myeloma drugs von Byrgazov, Konstantin, Kraus, Marianne, Besse, Andrej, Slipicevic, Ana, Lehmann, Fredrik, Driessen, Christoph, Besse, Lenka

Volltext

Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide von Byrgazov, Konstantin, Anderson, Claes, Salzer, Benjamin, Bozsaky, Eva, Larsson, Rolf, Gullbo, Joachim, Lehner, Manfred, Lehmann, Fredrik, Slipicevic, Ana, Kager, Leo, Fryknäs, Mårten, Taschner-Mandl, Sabine

Volltext

A Potential Role of NK Cells and ABCB9 in Modulating the Response to Melflufen in Multiple Myeloma von Sergeev, Philipp, Adhikari, Sadiksha, Miettinen, Juho J., Huppunen, Maiju-Emilia, Suvela, Minna, Slipicevic, Ana, Nupponen, Nina N., Acs, Klara, Lehmann, Fredrik, Heckman, Caroline A.

Volltext